GlassScriptPhysician profile
Paul B Payne
NPI 1104819986
$3,049.68
in general payments reported to CMS, 2019-2025
39 companies · $605 in 2025
The $605 reported for 2025 was more than what 84% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $570 · 2020: $313 · 2021: $236 · 2022: $606 · 2023: $365 · 2024: $354 · 2025: $605.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,324.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,323.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $593.30 | 2019-2023 | |
| Mayne Pharma Commercial LLC | $263.94 | 2021-2025 | |
| Shield Therapeutics INC | $223.45 | 2022-2025 | |
| Pfizer INC. | $214.54 | 2019-2025 | |
| Millicent US INC | $182.21 | 2020-2025 | Intrarosa, Femring, Femlyv |
| Coopersurgical, INC. | $137.54 | 2021-2025 | Endosee, Summit Doppler |
| Organon LLC | $127.55 | 2021-2025 | Nexplanon |
| Exeltis, USA INC. | $108.19 | 2020-2025 | Slynd |
| Sumitomo Pharma America, INC. | $98.23 | 2023-2025 | Myfembree |
| Sage Therapeutics, LLC | $92.04 | 2025 | Zurzuvae |
| Hologic Sales and Service, LLC | $90.19 | 2019-2023 | Acessa Provu System, Myosure Tissue Removal Device, Coolseal Generator |
| Teleflex LLC | $89.96 | 2019 | |
| Acessa Health INC. | $80.36 | 2019-2021 | |
| Amag Pharmaceuticals, INC. | $69.25 | 2019-2020 | |
| Astellas Pharma US INC | $57.39 | 2023-2025 | Veozah |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Payne listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.